Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: AbbVie CF Scholarship Program Open for 2020-21 School Year Kalydeco’s Use for 1 Year or More Seen to Aid Body Mass and Lung Capacity AbbVie CF Scholarship Program Open for 2020-21 School Year Apr 10, 2020 07:00 am | Vanessa Pataia University students with cystic fibrosis (CF) are invited to apply to AbbVie’s CF Scholarship program and a chance to receive up to $25,000 for the upcoming school year. The program supports U.S. residents with CF who are pursuing an undergraduate or graduate degree at an accredited institution. Applications, submitted online or through the post, are […] The post AbbVie CF Scholarship Program Open for 2020-21 School Year appeared first on Cystic Fibrosis News Today. Read More Kalydeco’s Use for 1 Year or More Seen to Aid Body Mass and Lung Capacity Apr 09, 2020 07:00 am | Vanessa Pataia Long-term treatment with Kalydeco (ivacaftor) in people with cystic fibrosis (CF) is associated with a better body mass index, lung function, and a lesser effort required to breath, a small study reports. The single-site study, “Long‐term effects of ivacaftor on nonpulmonary outcomes in individuals with cystic fibrosis, heterozygous for a S1251N mutation,” was published in the […] The post Kalydeco’s Use for 1 Year or More Seen to Aid Body Mass and Lung Capacity appeared first on Cystic Fibrosis News Today. Read More   Recent News More Training Needed in CF End-of-life Care, Small UK Survey Shows How Essential Am I? Case Report Describes Unusual CF Symptoms That Made Diagnosis Difficult How Isolation Has Brought Calm to My Life NORD’s Advice on COVID-19: You’re Stronger Than You Think